Adjunctive Bright Light Therapy for Opioid Use Disorder

NARecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 23, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

May 31, 2026

Conditions
Opioid Use DisorderSleep Disturbance
Interventions
DEVICE

Wearable bright light therapy device

Light treatment glasses (Re-timer®) will be used to deliver bright light therapy. This device is available commercially and allows participants to freely move around while receiving light from LEDs positioned below the eyes. Re-timer® can be worn over glasses and does not interfere with vision, reading, or computer work.

DEVICE

Wearable placebo light therapy device

The placebo Re-timer® emits light intensity to a level that will not impact sleep and circadian timing and appears identical to the original Re-timer®.

Trial Locations (1)

85004

RECRUITING

Arizona State University, Phoenix

All Listed Sponsors
lead

Arizona State University

OTHER